The cost‐effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2002-03-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1046/j.1365-2036.2002.01204.xPMID 11876711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

  2000cited by this paper
• The proportion of upper gastrointestinal symptoms in the community associated with helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs

  2000cited by this paper
• The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme

  2000cited by this paper
• Alimentary Pharmacology & Therapeutics

  1999cited by this paper
• Estimates of the worldwide mortality from 25 cancers in 1990

  1999cited by this paper
• Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies

  1999cited by this paper
• POPULATION-BASED AND OPPORTUNISTIC SCREENING AND ERADICATION OF HELICOBACTER PYLORI

  1999cited by this paper
• The DiSC ASSAY

  1999cited by this paper
• Should we go further and screen and treat?

  1999cited by this paper
• Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

  1999cited by this paper
• Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999).

  1999cited by this paper
• Variations in population health status: results from a United Kingdom national questionnaire survey

  1998cited by this paper
• Medical decision models of Helicobacter pylori therapy to prevent gastric cancer

  1998cited by this paper
• An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.

  1998cited by this paper
• Valvular heart disease: putting guidelines into practice

  1997cited by this paper
• Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.

  1997cited by this paper
• Do patients need to fast for a 13C‐urea breath test?

  1997cited by this paper
• Helicobacter pylori and gastric cancer.

  1996cited by this paper
• Helicobacter pylori and gastric cancer.

  1996cited by this paper
• Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners

  1996cited by this paper
• Accuracy of serology for the diagnosis of Helicobacter pylori infection--a comparison of eight kits.

  1996cited by this paper
• Clinical Economics Review: gastroenterology

  1996cited by this paper
• Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors.

  1996cited by this paper
• Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.

  1996cited by this paper
• Unit Costs of Health and Social Care 1997

  1996cited by this paper
• The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy.

  1995cited by this paper
• Five-hundred life-saving interventions and their cost-effectiveness.

  1995cited by this paper
• Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage.

  1995cited by this paper
• Helicobacter pylori and acute bleeding peptic ulcer.

  1995cited by this paper
• Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.

  1995cited by this paper
• Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial.

  1994cited by this paper
• Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs.

  1990cited by this paper
• A comparison between participants and non-participants in a primary preventive trial.

  1976cited by this paper

• Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies.

  2025cites this paper
• The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study

  2025cites this paper
• The Disease Burden of Helicobacter pylori Beyond Gastric Cancer: Quantifying the Forgotten Potential Benefits of Mass Eradication.

  2025cites this paper
• Current Status of Gastric Cancer Screening and Future Perspectives

  2025cites this paper
• A screen-and-treat strategy for eradication of Helicobacter pylori among patients with family history of gastric cancer in a diverse U.S. population.

  2024cites this paper
• Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population

  2024cites this paper
• Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

  2024cites this paper
• Current and Future Perspectives on the Management of Helicobacter pylori: A Narrative Review

  2024cites this paper
• Evolving Concepts in Helicobacter pylori management.

  2023cites this paper
• Helicobacter Pylori Related Gastric Cancer Screening and Cost-Effectiveness Analysis: A Hospital-Based Cross-Sectional Study (SIGES)

  2022cites this paper
• Mass screening and eradication of Helicobacter pylori as the policy recommendations for gastric cancer prevention.

  2022cites this paper
• Cost-effectiveness of prevention and early detection of gastric cancer in Western countries.

  2021cites this paper
• Case Histories of Significant Medical Advances: Eradicating Helicobacter Pylori Infections to Treat Ulcers

  2020cites this paper
• Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis

  2020cites this paper
• Helicobacter pylori eradication for the prevention of gastric neoplasia.

  2020cites this paper
• Helicobacter pylori eradication for the prevention of gastric neoplasia.

  2020cites this paper
• Who Needs Gastroprotection in 2020?

  2020cites this paper
• Title: Helicobacter pylori Eradication Therapy to Prevent Gastric Cancer: Systematic Review and Meta-analysis. Short running head: H. pylori Eradication Therapy to Prevent Gastric Cancer

  2020cites this paper
• Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model

  2019cites this paper
• Impact of Serum Interleukin 6 among Helicobacter Pylori-Positive Adult Patients in Relation to upper gastrointestinal endoscopy findings

  2019cites this paper
• The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up

  2019cites this paper
• The cost effectiveness of Helicobacter pylori population screening—economic evaluation alongside a randomised controlled trial with 13‐year follow‐up

  2019cites this paper
• National distribution of stomach cancer incidence in Iran: A population-based study

  2019cites this paper
• Helicobacter pylori management in ASEAN: The Bangkok consensus report

  2018cites this paper
• Simulation Models in Gastric Cancer Screening: A Systematic Review

  2018influential citation
• A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity

  2017cites this paper
• Population screening and treatment of Helicobacter pylori infection

  2017cites this paper
• Statistical and mathematical modeling to evaluate the cost-effectiveness of Helicobacter pylori screening and treating strategies in Mexico in the setting of antibiotic resistance

  2017cites this paper
• A Randomised Trial of empiric 14-day Triple, five-day Concomitant, and ten-day Sequential Therapies for Helicobacter pylori in Seven Latin American Sites

  2016cites this paper
• Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations

  2016cites this paper
• The Definitive Eradication of Helicobacter pylori from the Colon

  2015cites this paper
• An Alternate Natural Remedy for Symptomatic Relief of Helicobacter pylori Dyspepsia

  2015cites this paper
• A Comparative Study of Natural Eradication of Helicobacter pylori vs. Antibiotics

  2015cites this paper
• Helicobacter Pylori and Gastric Cancer: Clinical Aspects

  2015cites this paper
• Novel approaches to upper gastrointestinal conditions: a focus on bleeding and malignancy

  2014cites this paper
• Biomarkers for Gastric Cancer and the Related Premalignant Conditions

  2014cites this paper
• Efficacy and safety of herbal medicines in treating gastric ulcer: a review.

  2014cites this paper
• Helicobacter pylori: friend or foe?

  2014cites this paper
• Cost-effectiveness of screening and treating H. Pylori for gastric cancer prevention

  2014cites this paper
• Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

  2014cites this paper
• The Dramatic Spread of Diabetes Mellitus Worldwide and Influence of Helicobacter pylori

  2014cites this paper
• Helicobacter pylori: Evidence-Based Review with a Focus on Immigrant Populations

  2014cites this paper
• Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.

  2013cites this paper
• Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review

  2013cites this paper
• Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.

  2013cites this paper
• Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation

  2013cites this paper
• Screening for Gastric Cancer and Surveillance of Premalignant Lesions: a Systematic Review of Cost‐Effectiveness Studies

  2013cites this paper
• Vaccinating against Helicobacter pylori in the developing world

  2013cites this paper
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

  2012cites this paper
• The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention

  2012cites this paper
• 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

  2011cites this paper
• S3-Leitlinie „Magenkarzinom” –

  2011cites this paper
• WITHDRAWN: Psychological interventions for non-ulcer dyspepsia.

  2011cites this paper
• Adenocarcinoma and Other Tumors of the Stomach

  2010cites this paper
• Role of Helicobacter pylori infection in gastric cancer pathogenesis: A chance for prevention

  2010cites this paper
• Managing dyspepsia

  2009cites this paper
• Cost‐Effectiveness of Eradication of Helicobacter pylori in Gastric Cancer Survivors After Endoscopic Resection of Early Gastric Cancer

  2009cites this paper
• The Maastricht III consensus: summary and comments.

  2009cites this paper
• Helicobacter pylori Infection in Developing Countries: The Burden for How Long?

  2009cites this paper
• REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY

  2009cites this paper
• Estudio del beneficio clínico y de coste-efectividad tras efectuar sistemáticamente una segunda gastroscopia en la úlcera gástrica benigna

  2009cites this paper
• Epidemiology of Gastric Cancer and Helicobacter pylori

  2009cites this paper
• [Analysis of the clinical benefits and cost-effectiveness of performing a systematic second-look gastroscopy in benign gastric ulcer].

  2009cites this paper
• Exploring the cost‐effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results

  2009cites this paper
• Helicobacter pylori Pathogenesis and Vaccines

  2008cites this paper
• Screening for gastric cancer in Asia: current evidence and practice.

  2008cites this paper
• Is eradication of Helicobacter pylori the feasible way to prevent gastric cancer? New evidence and progress, but still a long way to go.

  2008cites this paper
• Should We Screen for Helicobacter pylori to Prevent Gastric Cancer?

  2007cites this paper
• Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update

  2007cites this paper
• The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori Infection

  2007cites this paper
• Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance Strategies

  2007cites this paper
• Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer

  2007cites this paper
• The health economics of Helicobacter pylori infection.

  2007cites this paper
• How to Influence Health Providers

  2007cites this paper
• Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence

  2007cites this paper
• Eradication therapy for Helicobacter pylori.

  2007cites this paper
• Review article: Helicobacter pylori eradication for the prevention of gastric cancer

  2007cites this paper
• Helicobacter pylori eradication for premalignant lesions of the gastric mucosa

  2007cites this paper
• Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial

  2007cites this paper
• Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer

  2006cites this paper
• Helicobacter pylori y cáncer gástrico

  2006cites this paper
• Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial

  2006cites this paper
• Who benefits from Helicobacter pylori eradication?

  2006cites this paper
• The global health burden of infection‐associated cancers in the year 2002

  2006cites this paper
• Helicobacter pylori Eradication for the Prevention of Gastric Cancer

  2006cites this paper
• Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique

  2005cites this paper
• Tratamiento erradicador de Helicobacter pylori en la enfermedad no

  2005cites this paper
• A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.

  2005influential citation
• [Helicobacter pylori eradication treatment in non-ulcerous disease].

  2005cites this paper
• A Systematic Review of Psychological Therapies for Nonulcer Dyspepsia

  2004cites this paper
• Cost-benefit analysis of Helicobacter pylori screening.

  2004cites this paper
• Papel de los modelos en las evaluaciones económicas en el campo sanitario

  2004cites this paper
• Helicobacter pylori test‐and‐treat strategy in the management of dyspepsia in primary care: an overview

  2004cites this paper
• Helicobacter pylori and gastroesophageal reflux disease: a complex organism in a complex host.

  2004cites this paper
• Helicobacter pylori Public Health Implications

  2004cites this paper
• Accelerated decline in Helicobacter pylori seroprevalence rate during the screen and treat project in Vammala, Finland, as demonstrated in 29‐ to 45‐year‐old pregnant women

  2004cites this paper
• Diagnosis and treatment of Helicobacter: a 2002 updated review

  2003cites this paper
• [Could Helicobacter pylori treatment reduce stomach cancer risk?].

  2003cites this paper
• Cost-Effectiveness of Population Screening for Helicobacter Pylori in Preventing Gastric Cancer and Peptic Ulcer Disease, Using Simulation

  2003cites this paper
• Ethical issues in the management of Helicobacter pylori infection.

  2003cites this paper